These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10383900)

  • 1. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).
    Yuann JM; Liu KJ; Hamilton JW; Wetterhahn KE
    Carcinogenesis; 1999 Jul; 20(7):1267-75. PubMed ID: 10383900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two pathways for chromium(VI)-induced DNA damage in 14 day chick embryos: Cr-DNA binding in liver and 8-oxo-2'-deoxyguanosine in red blood cells.
    Misra M; Alcedo JA; Wetterhahn KE
    Carcinogenesis; 1994 Dec; 15(12):2911-7. PubMed ID: 8001255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates.
    Standeven AM; Wetterhahn KE
    Carcinogenesis; 1991 Sep; 12(9):1733-7. PubMed ID: 1893533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by Chromium(VI) reduction with ascorbate.
    Tsou TC; Lai HJ; Yang JL
    Chem Res Toxicol; 1999 Oct; 12(10):1002-9. PubMed ID: 10525278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro.
    Standeven AM; Wetterhahn KE
    Carcinogenesis; 1992 Aug; 13(8):1319-24. PubMed ID: 1499083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
    Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
    Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
    Quievryn G; Messer J; Zhitkovich A
    Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo formation of chromium(V) in chick embryo liver and red blood cells.
    Liebross RH; Wetterhahn KE
    Carcinogenesis; 1992 Nov; 13(11):2113-20. PubMed ID: 1330350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromium(III)-induced 8-hydroxydeoxyguanosine in DNA and its reduction by antioxidants: comparative effects of melatonin, ascorbate, and vitamin E.
    Qi W; Reiter RJ; Tan DX; Garcia JJ; Manchester LC; Karbownik M; Calvo JR
    Environ Health Perspect; 2000 May; 108(5):399-402. PubMed ID: 10811565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vanadium(V) and/or chromium(III) on L-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney.
    Scibior A; Zaporowska H
    J Toxicol Environ Health A; 2007 Apr; 70(8):696-704. PubMed ID: 17365624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate.
    Quievryn G; Messer J; Zhitkovich A
    Carcinogenesis; 2006 Nov; 27(11):2316-21. PubMed ID: 16714765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects.
    Mãrtensson J; Meister A
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4656-60. PubMed ID: 2052548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic cooperation of ascorbic acid and glutathione in normal and vitamin C-deficient ODS rats.
    Wang Y; Kashiba M; Kasahara E; Tsuchiya M; Sato EF; Utsumi K; Inoue M
    Physiol Chem Phys Med NMR; 2001; 33(1):29-39. PubMed ID: 11758733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
    Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
    J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats.
    Standeven AM; Wetterhahn KE
    Pharmacol Toxicol; 1991 Jun; 68(6):469-76. PubMed ID: 1891442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of paramagnetic chromium in liver of mice treated with dichromate (VI).
    Ueno S; Susa N; Furukawa Y; Sugiyama M
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):165-71. PubMed ID: 8545823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanine-specific oxidation of double-stranded DNA by Cr(VI) and ascorbic acid forms spiroiminodihydantoin and 8-oxo-2'-deoxyguanosine.
    Slade PG; Hailer MK; Martin BD; Sugden KD
    Chem Res Toxicol; 2005 Jul; 18(7):1140-9. PubMed ID: 16022506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice.
    Cheng L; Sonntag DM; de Boer J; Dixon K
    J Environ Pathol Toxicol Oncol; 2000; 19(3):239-49. PubMed ID: 10983890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascorbate is a pro-oxidant in chromium-treated human lung cells.
    Martin BD; Schoenhard JA; Hwang JM; Sugden KD
    Mutat Res; 2006 Nov; 610(1-2):74-84. PubMed ID: 16857421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.